The medical devices industry continues to be a hotbed of patent innovation. Activity is driven by increased need for homecare, preventative treatments, early diagnosis, reducing patient recovery times and improving outcomes, as well as a growing importance in technologies, such as machine learning, augmented reality, 5G and digitalization. In the last three years alone, there have been over 710,000 patents filed and granted in the medical devices industry, according to GlobalData’s report on Internet of Things in medical: NFC implants. Buy the report here.
However, not all innovations are equal and nor do they follow a constant upward trend. Instead, their evolution takes the form of an S-shaped curve that reflects their typical lifecycle from early emergence to accelerating adoption, before finally stabilizing and reaching maturity.
Identifying where a particular innovation is on this journey, especially those that are in the emerging and accelerating stages, is essential for understanding their current level of adoption and the likely future trajectory and impact they will have.
120+ innovations will shape the medical devices industry
According to GlobalData’s Technology Foresights, which plots the S-curve for the medical devices industry using innovation intensity models built on over 487,000 patents, there are 120+ innovation areas that will shape the future of the industry.
Within the emerging innovation stage, programmable infusion devices, wearable sleep assistance devices, and context-aware patient monitoring are disruptive technologies that are in the early stages of application and should be tracked closely. Remote dialysis monitoring, NFC implants, and medical ERS are some of the accelerating innovation areas, where adoption has been steadily increasing. Among maturing innovation areas are body area network (BAN), which is now well established in the industry.
Innovation S-curve for Internet of Things in the medical devices industry
NFC-enabled implants is a key innovation area in Internet of Things
Medical implants, particularly sensory and electric implants to monitor and rehabilitate organ states, are coupled with near-field communication (NFC) chips to allow for short-distance communication with user devices. NFC-enabled implants are particularly beneficial in emergency cardiac care. NFC can be a handy technology for data transfer between two devices that are close to each other. It is more secure than other wireless technologies, such as Bluetooth and Wi-Fi, since it requires the two devices to be in close contact with one another (less than 10cm).
Machine-to-machine communication in medical devices is increasing in healthcare. As gadgets grow smarter and more networked, the demand for data transfer between devices located outside the body (in vitro) and within the body (in vivo) will rise.
GlobalData’s analysis also uncovers the companies at the forefront of each innovation area and assesses the potential reach and impact of their patenting activity across different applications and geographies. According to GlobalData, there are 90+ companies, spanning technology vendors, established medical devices companies, and up-and-coming start-ups engaged in the development and application of NFC-enabled implants.
Key players in NFC-enabled implants – a disruptive innovation in the medical devices industry
‘Application diversity’ measures the number of applications identified for each patent. It broadly splits companies into either ‘niche’ or ‘diversified’ innovators.
‘Geographic reach’ refers to the number of countries each patent is registered in. It reflects the breadth of geographic application intended, ranging from ‘global’ to ‘local’.
Patent volumes related to NFC-enabled implants
Company | Total patents (2010 - 2021) | Premium intelligence on the world's largest companies |
Boston Scientific Corp | 109 | Unlock company profile |
Nyxoah SA | 101 | Unlock company profile |
Baxter International Inc | 65 | Unlock company profile |
Medtronic Plc | 52 | Unlock company profile |
Cochlear Ltd | 49 | Unlock company profile |
NuCurrent Inc | 46 | Unlock company profile |
Alphabet Inc | 44 | Unlock company profile |
Koninklijke Philips NV | 43 | Unlock company profile |
Abbott Laboratories | 43 | Unlock company profile |
Demant A/S | 34 | Unlock company profile |
The Alfred Mann Foundation | 23 | Unlock company profile |
Samsung Group | 23 | Unlock company profile |
NXP Semiconductors NV | 23 | Unlock company profile |
Sonova Holding AG | 21 | Unlock company profile |
Schleifring und Apparatebau GmbH | 21 | Unlock company profile |
WiTricity Corporation | 20 | Unlock company profile |
Sony Group Corp | 18 | Unlock company profile |
Johnson & Johnson | 18 | Unlock company profile |
Man & Science SA | 18 | Unlock company profile |
Qualcomm Inc | 16 | Unlock company profile |
Align Technology Inc | 14 | Unlock company profile |
EarLens Corp | 14 | Unlock company profile |
Murata Manufacturing Co Ltd | 13 | Unlock company profile |
Enovate Medical | 13 | Unlock company profile |
NeuSpera Medical Inc | 13 | Unlock company profile |
Implantica Patent Ltd | 12 | Unlock company profile |
Nuxcel, Inc. | 12 | Unlock company profile |
Nokia Corp | 12 | Unlock company profile |
British American Tobacco Plc | 11 | Unlock company profile |
ReShape Lifesciences Inc | 10 | Unlock company profile |
Fraunhofer-Gesellschaft zur Forderung der Angewandten Forschung eV | 10 | Unlock company profile |
Apple Inc | 9 | Unlock company profile |
WS Audiology AS | 9 | Unlock company profile |
Infineon Technologies AG | 9 | Unlock company profile |
Energous Corporation | 8 | Unlock company profile |
Morgan Stanley | 8 | Unlock company profile |
Stryker Corp | 8 | Unlock company profile |
Starkey Hearing Technologies Inc | 7 | Unlock company profile |
Vascor Ltd | 7 | Unlock company profile |
GSK plc | 7 | Unlock company profile |
Ubiquity Biomedical Corporation | 7 | Unlock company profile |
MED-EL Elektromedizinische Gerate Gesellschaft mbH | 7 | Unlock company profile |
Nalu Medical Inc | 7 | Unlock company profile |
Hangzhou Nanochap Electronics Co., Ltd | 7 | Unlock company profile |
Olympus Corp | 6 | Unlock company profile |
Milux Holding Sa | 6 | Unlock company profile |
Sanofi | 6 | Unlock company profile |
Saluda Medical Pty Ltd | 6 | Unlock company profile |
Altaris Capital Partners LLC | 6 | Unlock company profile |
Toshiba Corp | 6 | Unlock company profile |
Source: GlobalData Patent Analytics
Boston Scientific and Nyxoah are two of the leading patent filers in NFC-enabled implants. Some other leading patent filers include Baxter International, Medtronic, Cochlear, NuCurrent, Alphabet, and Abbott Laboratories.
In terms of application diversity, Enovate Medical leads the pack, followed by British American Tobacco and Vascor. With regards to geographic reach, Baxter International holds the top position, followed by Nyxoah and Man & Science in second and third spots, respectively.
The importance of a secure communication channel in the medical device realm cannot be overstated, and it is a top priority to ensure communication between medical devices is quick and secure. With its security and communication advantages, NFC is the obvious choice for wireless communication between medical equipment. There are many cases of medical application, such as implanted devices which must be very energy efficient to remain in the body for years. NFC protocols are particularly suited for such applications since the reader can only activate the tag when necessary and can also wirelessly transmit power.
To further understand the key themes and technologies disrupting the medical devices industry, access GlobalData’s latest thematic research report on Medical Devices.
Premium Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.